Cardiovascular Abnormalities: Clinical Trials

10 trials for Cardiovascular Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 recruiting. 10 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Recruiting 10
Phase 25Recruiting 5

Follow Cardiovascular Abnormalities: new trials by email Literature Review of Cardiovascular Abnormalities trials Research Report on Cardiovascular Abnormalities

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ATR 1072 in Participants With PRKAG2 Syndrome
ATR 1072 - Cardiac Glycogenosis, Cardiomyopathy
Phase 1 / Phase 2RecruitingAtrium Therapeutics372026-09-142026-09-18
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
ATV-1601, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
Phase 1 / Phase 2RecruitingAtavistik Bio, Inc1002026-07-272026-10-26
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
DIAG723, Placebo - Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
Phase 1 / Phase 2RecruitingDiagonal Therapeutics, Inc.932026-06-042026-09-08
A Multiple Baseline Feasibility Trial of Social Management Training for People With Sex Chromosome Aneuploidies
Social Management Training - Sex Chromosome Disorders
Phase 1RecruitingUniversity of Oslo302026-06-012026-07-22
Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children
End-expiratory lung volume optimization maneuver with PEEP titration, Standard Care (in control arm) - Congenital Heart Disease, Cardiopulmonary Bypass
Phase 1 / Phase 2RecruitingCharite University, Berlin, Germany802025-12-052026-10-15
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
TN-401 - Arrhythmogenic Right Ventricular Cardiomyopathy
Phase 1RecruitingTenaya Therapeutics152024-03-262025-02-06
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
RP-A601 - PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1RecruitingRocket Pharmaceuticals Inc.92023-08-292026-04-16
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
iPSC-CL - Univentricular Heart, Congenital Heart Disease
Phase 1RecruitingHeartWorks, Inc.502023-02-032026-03-13
Beta-blocker Administration for Cardiomyocyte Division
N-thymidine, Urine Collection, Echocardiogram - Tetralogy of Fallot, Double Outlet Right Ventricle
Phase 1RecruitingWeill Medical College of Cornell University402022-12-162026-10-26
Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Al18F-NOTA-FAPI PET/CT(or PET/MRI) - Hyperthyroidism, Autoimmune, Cardiovascular Abnormalities
Phase 1 / Phase 2RecruitingPeking Union Medical College Hospital6002022-05-102026-02-10

Narrower conditions

Arrhythmogenic Right Ventricular Dysplasia (2)  ·  Heart Defects, Congenital (2)  ·  Telangiectasia, Hereditary Hemorrhagic (2)  ·  47, XYY syndrome (1)  ·  Arteriovenous Malformations (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Death, Sudden, Cardiac (1)  ·  Disease (1)  ·  Double Outlet Right Ventricle (1)  ·  Glycogen Storage Disease (1)  ·  Graves Disease (1)  ·  Heart Arrest (1)  ·  Heart Diseases (1)

Broader conditions

Congenital Abnormalities (10)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10)  ·  Cardiovascular Diseases (9)  ·  Heart Diseases (6)  ·  Heart Defects, Congenital (5)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Cardiomyopathies (2)  ·  Endocrine System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Pathologic Processes (2)  ·  Arrhythmias, Cardiac (1)  ·  Autoimmune Diseases (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)

Interventions

Capsules (1)  ·  Propranolol (1)  ·  Restraint, Physical (1)  ·  Specimen Handling (1)  ·  Standard of Care (1)  ·  Thymidine (1)  ·  Urine Specimen Collection (1)

Sponsors

Atavistik Bio, Inc (1)  ·  Atrium Therapeutics (1)  ·  Charite University, Berlin, Germany (1)  ·  Diagonal Therapeutics, Inc. (1)  ·  HeartWorks, Inc. (1)  ·  Peking Union Medical College Hospital (1)  ·  Rocket Pharmaceuticals Inc. (1)  ·  Tenaya Therapeutics (1)  ·  University of Oslo (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (6)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Germany (1)  ·  New Zealand (1)  ·  Norway (1)

Top investigators

Barry Greenberg, MD (1)  ·  Bernhard Kuhn, MD (1)  ·  Timothy J Nelson, M.D., Ph.D. (1)

Results publications

PMID 34265312, PMID 37979797, PMID 42660999

NIH funding

R01HL155597 (1)